KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Treasury Shares (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Treasury Shares for 14 consecutive years, with $1.0 billion as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 30.76% to $1.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.0 billion through Dec 2025, up 30.76% year-over-year, with the annual reading at $1.0 billion for FY2025, 30.76% up from the prior year.
  • Treasury Shares for Q4 2025 was $3.3 million at Bio-Rad Laboratories, roughly flat from $3.3 million in the prior quarter.
  • The five-year high for Treasury Shares was $3.5 million in Q1 2025, with the low at $124333.0 in Q2 2024.
  • Average Treasury Shares over 5 years is $1.3 million, with a median of $651787.5 recorded in 2021.
  • Peak annual rise in Treasury Shares hit 147.99% in 2022, while the deepest fall reached 29.1% in 2022.
  • Over 5 years, Treasury Shares stood at $106.3 million in 2021, then surged by 147.99% to $263.6 million in 2022, then skyrocketed by 139.96% to $632.5 million in 2023, then grew by 22.07% to $772.1 million in 2024, then surged by 30.76% to $1.0 billion in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $1.0 billion, $1.0 billion, and $1.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.